TB or not TB - or DR-TB? Introducing a new EQA scheme for Mycobacterium tuberculosis drug resistance
Labquality, a Finnish independent EQA provider, has introduced a new EQA scheme for Mycobacterium tuberculosis, drug resistance (DR), by performing a pilot study named Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection in June 2022.
Fill in the form and download the poster
